ischemia; vascular biology PHLEBOTOMY (BLOODLETTING) is the frequent withdrawal of considerable quantities of blood from a patient for the purpose of curing or preventing illness. Although it was commonly practiced from antiquity up to the late 19th century, the practice has since been abandoned for all but a few very specific conditions, because in the overwhelming majority of cases phlebotomy is harmful to patients (19) . Today, therapeutic phlebotomy refers to the drawing of a unit of blood in specific cases, such as hemochromatosis, polycythemia vera, porphyria cutanea tarda, or congestive heart failure, to reduce the numbers of red blood cells or the blood volume (9, 19, 24) . The blood loss is, in turn, compensated by erythrogenesis through erythropoietin production, mainly in the kidney (20) . Recently, however, erythropoietin has been attracting attention for its multiple extraerythrogenic actions, among which is its potent angiogenic action mediated directly and via mobilization of endothelial progenitor cells (EPCs) (10, 22) . Anemia causes tissue hypoxia, and mild to moderate hypoxia is known to stabilize angiogenic hypoxia-inducible transcription factor (HIF)-1␣ (21) . We therefore hypothesized that controlled phlebotomy may enhance angiogenesis in ischemic tissue, perhaps through the induction of endogenous erythropoietin and hypoxic tissuederived angiogenic factors. In the present study, we tested that hypothesis in a mouse model of leg ischemia.
MATERIALS AND METHODS
Operative procedure and treatments. This study was approved by the Institutional Animal Research Committee of Gifu University and conforms to the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996). Male 9-wk-old BALB/c mice were purchased from Japan SLC (Shizuoka, Japan). Under sufficient anesthesia with pentobarbital sodium, the local fur was removed with depilatory cream. Hindlimb ischemia was induced by a complete ligation of the right femoral artery at a point just below the inguinal ligament, as previously described (16) . In sham-operated mice (n ϭ 8), the suture was passed through but not tied.
After ligation, mice were randomly assigned to control (n ϭ 7) and phlebotomy (n ϭ 8) groups. In the latter, 200 l blood were drawn via the tail vein on the day of the femoral artery ligation and 1, 2, and 3 wk later. Hemoglobin was measured using the standardized method.
In other experiments, after the femoral artery ligation, mice in the control and phlebotomy groups were given wortmannin (16 g·kg Ϫ1 · day Ϫ1 , Sigma), a phosphoinositide 3-kinase (PI3K) inhibitor (n ϭ 7 for control vs. n ϭ 9 for bloodletting); N -nitro-L-arginine methyl ester (L-NAME; 1 mg/ml in drinking water; Sigma), an endothelial nitric oxide synthase (eNOS) inhibitor (n ϭ 9 for control vs. n ϭ 9 for bloodletting); or AMD3100 (200 g·kg Ϫ1 · day Ϫ1 ; sigma), a specific chemokine receptor CXCR4 antagonist that disrupts the CXCR4/stromal cell-derived factor-1 axis (n ϭ 8 for control vs. n ϭ 9 for bloodletting) (11) . Wortmannin and AMD3100 were administered using subcutaneously embedded osmotic minipumps (Alzet), whereas L-NAME was added to the drinking water. The administration of the reagents was begun on the day of surgery and continued until death.
Laser-doppler imaging. After anesthesia, hair was removed from both legs using a depilatory cream, following which the mice were placed on a heating plate at 37°C for 10 min to minimize temperature validation.
The ischemic limb (right)-to-nonischemic limb (left) blood flow ratio was measured using a laser-Doppler perfusion imager (Moor Instruments). The laser-Doppler perfusion imager provides a nonin-vasive measurement of blood flow by determining the Doppler frequency shift due to light reflecting off the moving red blood cells. Data acquisition was performed in a method similar to Rivard et al. (23) . Briefly, the sedated mice were secured on a monochromatic surface, and an area of 11 ϫ 11 cm was scanned from the lower abdomen to the end of the toes. Color images were obtained and hindlimb perfusion ratios were determined by comparing the perfusion of the hindlimb before surgery to that of specified time points: postsurgery and 1, 2, 3, and 4 wk. An ischemic Doppler ratio was established for all groups and compared.
Hematopoietic cytokine levels in the serum. Blood was collected at the end of the experiment (4 wk after ligation), and serum levels of erythropoietin, granulocyte colony-stimulating factor (G-CSF), and thrombopoietin were measured using enzyme immunoassay kits (R&D Systems).
Immunohistochemical analysis. Deparaffinized sections (4 m thick) from the lower calf muscles were incubated with primary antibodies against CD31 and ␣-smooth muscle actin (␣-SMA; 1A4) (both from Dako Japan). An ABC kit (Vector) was then used for immunostaining, with diaminobenzidine HCl serving as the chromogen. Nuclei were counterstained with hematoxylin. Quantitative assessments, including the number or area of immunopositive cells, were made in 20 randomly chosen high-power fields (ϫ400) using a multipurpose color image processor. The CD31-positive vessel density was also expressed as the number of the CD31-positive vessels per muscle fiber (2) .
Western blot analysis. Lysates from hindlimb muscle tissue homogenates harvested 8 days after surgery were used for Western blot analysis. Proteins were separated and transferred to membranes using standard protocols, after which they were probed with antibodies against HIF-1␣ (Abcam), vascular endothelial growth factor (VEGF; Santa Cruz), Akt (Cell Signaling), and eNOS (Cell Signaling). The activity of Akt and eNOS was evaluated in the muscular specimens 8 days after surgery by Western blot analysis for their phosphorylated forms using antibodies against the phosphorylated (p)-Akt (Cell Signaling) and p-eNOS (BD Pharmingen). Three to five specimens each from hindlimb muscles on the ischemic and nonischemic sides were subjected to the blotting. The blots were visualized by means of Fluorescence-activated cell sorter analysis. Peripheral blood mononuclear cells were isolated from mice in each group (n ϭ 6 each) on day 10 after surgery using density gradient centrifugation with Ficoll (Immuno-Biological Laboratories). Light density mononuclear cells were harvested and washed twice with phosphate-buffered saline, after which EPCs were identified based on positive staining for CD34 and Sca-1 (CD34 ϩ /Sca-1 ϩ ), CD34 and Flk-1 (CD34 ϩ /Flk-1 ϩ ), or CD34 and CD133 (CD34 ϩ /CD133 ϩ ). The antibodies against CD34 and Sca-1 were purchased from BD Bioscience; those against CD133 and Flk-1 were from e-Bioscience. FITC-conjugated anti-mouse CD4 and anti-rat IgG2a antibodies served as controls (BD Pharmingen). After incubation, erythrocytes were lysed using the fluorescence-activated cell sorter (FACS) lysing solution. Cells were then washed with phosphate-buffered saline and analyzed using a FACS Caliber (Becton Dickinson). Each analysis included 100,000 events.
Statistical analysis. Values are shown as means Ϯ SE. The significance of differences between groups was evaluated using one-way ANOVA followed by the Newman-Keuls multiple comparison test. For statistical analysis of blood flow ratios, we used a repeatedmeasures ANOVA. Values of P Ͻ 0.05 were considered significant.
RESULTS

Hemocount.
Phlebotomy was performed just after femoral artery ligation and once a week for 3 wk thereafter (Fig. 1A) . Drawing blood caused a significant decrease in hemoglobin levels (14.4 Ϯ 0.2 g/dl), compared with the sham-operated (15.6 Ϯ 0.2 g/dl, P Ͻ 0.05) and ischemia alone (control) groups (15.7 Ϯ 0.2 g/dl, P Ͻ 0.05).
Blood perfusion in the ischemic leg. Laser-Doppler imaging revealed that blood flow in the ischemic limbs of mice in the phlebotomy group showed substantial recovery 2 wk after surgery, and blood flow continued to improve until 4 wk after surgery (Fig. 1B) . Such recovery was not seen in the control group (Fig. 1C) .
Immunohistochemical staining for CD31, an endothelial cell marker, and for ␣-SMA, an arteriole marker, revealed that the numbers of CD31 ϩ cells (mostly capillary endothelial cells), but not ␣-SMA ϩ cells, were increased in the phlebotomy group (Fig. 2) . The CD31
ϩ cells-to-muscle fiber ratio was also confirmed to be significantly increased in the phlebotomy group (Fig. 2) . This suggests that phlebotomy stimulates the proliferation of capillaries but not arterioles in the ischemic leg.
Hematopoietic cytokines. Serum levels of G-CSF, but not erythropoietin and thrombopoietin, were elevated in mice with leg ischemia (Fig. 3A) . Phlebotomy significantly increased serum erythropoietin levels but did not cause further increases in serum G-CSF levels and reduced serum thrombopoietin levels (Fig. 3A) .
Angiogenic factors. Western blot analysis revealed that the expression of HIF-1␣ and VEGF was significantly higher in the ischemic legs (Fig. 3B) . Moreover, phlebotomy significantly augmented the increase in those angiogenic factors in the ischemic legs.
Not only the expression but also the activation level of both Akt and eNOS in the ischemic legs was significantly increased by phlebotomy (Fig. 3B) . When we then inhibited the activities of Akt or eNOS, using wortmannin or L-NAME, respectively, we found that either treatment significantly attenuated the improvement in blood flow brought about by phlebotomy (Fig. 4,  A and B) . This suggests that the improved blood flow stimulated by phlebotomy is dependent on the signaling in the Akt/eNOS pathway. Treatment with wortmannin inhibited both Akt and eNOS activation in the ischemic leg of mice that received phlebotomy, whereas L-NAME inhibited only eNOS but not Akt activation (Fig. 5) , suggesting an upstream regulation of Akt activation on eNOS activation, consistent with the previous finding in endothelial cells (6) .
EPC mobilization. Because erythropoietin is reported to be a potent stimulus of EPC mobilization (10), we examined the effect of phlebotomy on the mobilization of EPCs identified based on their CD34
ϩ phenotype. We found no significant mobilization of EPCs in the control group, which is consistent with our earlier finding that a simple ligation of the femoral artery does not induce significant EPC mobilization in BALB/c mice (15) . However, the addition of phlebotomy led to a significant EPC mobilization in mice with leg ischemia (Fig. 6) . Treatment with AMD3100 blocked the phlebotomy-mediated improvement of blood flow in the ischemic leg (Fig. 4C) , supporting the notion that EPC mobilization is involved in the beneficial effect of phlebotomy on blood flow.
Relation between the Akt/eNOS pathway and EPC mobilization. Our data suggest that both Akt/eNOS pathway and EPC mobilization possibly contribute to the beneficial effect of phlebotomy on blood flow in the ischemic legs. Thus we next examined the relationship between them. The inhibition of EPC mobilization with AMD3100 suppressed eNOS activation but not Akt activation (Fig. 5) , suggesting that eNOS activity is implicated in the recruited EPCs. On the other hand, the suppression of Akt and eNOS activity with wortmannin and L-NAME, respectively, was found to significantly inhibit EPC mobilization (Fig. 6 ). This finding suggests that EPC mobilization depends on the Akt/eNOS pathway in this experimental setting.
DISCUSSION
Although phlebotomy is an ancient medical practice that has been abandoned in modern medicine, except for a very few specific conditions, the present study has, for the first time, shed light on its angiogenic effect on ischemic tissue.
Mechanisms responsible for the benefits of phlebotomy. We found that controlled phlebotomy improves blood flow in mouse legs rendered ischemic by ligation of the femoral artery. This beneficial effect appears to reflect increased numbers of capillary vessels, which is indicative of enhanced angiogenesis. Phlebotomy was confirmed to increase serum erythropoietin levels as well as levels of HIF-1␣ and VEGF in the ischemic legs, suggesting that anemia enhances the hypoxic response in ischemic legs. The levels of HIF-1␣ activated in response to hypoxia correlate with tumorigenicity and angiogenesis in nude mice (17) . Activated HIF-1␣ positively regulates the expression of numerous genes, including erythropoietin and VEGF (7, 8, 21) , both of which are known to exert angiogenic effects through the activation of the PI3K/Akt pathway (13, 14) . Akt activation leads to eNOS activation and nitric oxide production (5, 6) , and PI3K/Akt signaling can feed back to further stimulate HIF-1␣ and VEGF activity (13) . In the present study, treatment with either wortmannin or L-NAME reversed the effect of phlebotomy on blood flow improvement, which further supports the involvement of the Akt/eNOS pathway in the beneficial effect of phlebotomy.
Erythropoietin is a potent angiogenic factor that is also able to mobilize EPCs from bone marrow into the systemic circulation (10) . The present FACS analysis revealed that phlebotomy augmented EPC mobilization and that treatment with AMD3100 blocked the effect of phlebotomy, which suggests the homing mechanism of EPCs (vasculogenesis) is essential for its benefits. It is noteworthy that wortmannin, L-NAME, or AMD3100 could nearly and completely block the beneficial effects of phlebotomy. This suggests to us that there is considerable and complicated cross talk between the angiogenic signals and EPCs. At the molecular level, several studies actually indicate that the Akt pathway may play an important role in EPCs (5) . VEGF and EPO are well known to augment the Akt pathway (3) . Based on the finding that eNOS is essential for the mobilization of bone marrow-derived stem and progenitor cells (1), one may speculate that these stimuli may increase progenitor cell mobilization by Akt-dependent activa- tion of the eNOS within the bone marrow stromal cells. Consistent with this idea, exercise-and VEGF-stimulated EPC mobilization was abolished in eNOS-deficient mice (15) . On the other hand, our data showed that the inhibition of EPC mobilization with AMD3100 significantly suppresses eNOS activation (but not Akt activation) in the ischemic legs receiving phlebotomy. This finding is consistent with the previous study reporting that EPCs recruited to the ischemic myocardium play a unique role as repositories of eNOS activity; EPCs express the active form of eNOS (p-eNOS) (12) . Collectively, it is suggested that phlebotomy augments Akt/eNOS activity in the ischemic tissue in addition to HIF-1␣ and VEGF and also induces Akt/eNOS pathway-dependent mobilization of EPCs that contain eNOS activity. The combined effects of them seem to induce vasculogenesis, resulting in an improvement of blood flow in the ischemic leg. Further investigation is warranted on the molecular mechanisms that are surmised to be much more complicated in the effect of phlebotomy on ischemic tissue.
Implications of the present study. The control ischemic group (ischemia alone) in the present study showed only ϳ60% recovery of blood flow even at 4 wk after ligation.
Although this observation appears conflicting with those of previous studies where blood flow of the ischemic limb was quickly restored to nearly nonischemic level at 2 to 4 wk after a simple ligation of the femoral artery (4, 18, 25, 26) , it should be noted that there is a difference in the mouse strains between the present and previous studies (BALB/c vs. C57BL/6). Different from the C57BL/6 mice, a most commonly used strain, showing very active angiogenic activity, BALB/c mice show less angiogenic activity in ischemic legs like humans as we previously reported (16) . The similarity to humans in angiogenesis was the most critical reason that we decided to choose the BALB/c strain as the model. Animal experiments sometimes need frequent blood sampling according to the protocols. Our present findings imply an unexpected influence of serial blood collections for extended periods of time on the animals holding some ischemic conditions (i.e., increasing angiogenic activity in the ischemic tissue), suggesting the requirement of a proper selection of control groups in such experiments. Thus the present results are of significant interest within the scientific community working on angiogenesis.
We propose that adequately controlled phlebotomy could be considered as one method for inducing therapeutic angiogenesis. The cost is extremely low unlike the other procedures for therapeutic angiogenesis, e.g., gene therapy and stem or progenitor cell transplantation. With each phlebotomy, we withdrew about 200 l of blood from the mice in this study, which corresponds to ϳ500 ml in 60 kg in humans. Mild anemia may have another benefit for patients with vascular disease, as it would temper blood hyperviscosity that can lead to the formation of thromboemboli. On the other hand, an anticipated disadvantage is the promotion of tumor growth because of the enhanced angiogenic tendency. Thus very careful protocols, including a strict definition of contraindications, are necessary before clinical application.
Finally, phlebotomy caused an increase of capillary vessels but not of arterioles during the observation period for 4 wk. However, it would be interesting to investigate whether repeated phlebotomy can affect the arteriogenesis process at the later phase, which can be serially evaluated with contrast microCT technique.
